Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2002
08/08/2002CA2436133A1 Receptor selective cannabimimetic aminoalkylindoles
08/08/2002CA2432642A1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
08/08/2002CA2431559A1 Process for making substituted 8-arylquinolinium benzenesulfonate
08/08/2002CA2427610A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
08/07/2002EP1229035A1 Imine intermediates for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties
08/07/2002EP1229034A1 Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes
08/07/2002EP1229033A2 2-Fluoro-(oxid-thiopyran-4-yl)benzene derivatives
08/07/2002EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
08/07/2002EP1228759A2 Pharmaceutical compositions containing a taxane having a furyl or thienyl substituted side-chain
08/07/2002EP1228071A1 Pharmaceutically active isoindoline derivatives
08/07/2002EP1228068A1 Polymorphic form of a tachykinin receptor antagonist
08/07/2002EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity
08/07/2002EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
08/07/2002EP1228048A1 Sordaricin derivatives having antifungal activity
08/07/2002EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy
08/07/2002EP1077976B1 Water soluble azoles as broad-spectrum antifungals
08/07/2002EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
08/07/2002CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor
08/07/2002CN1362951A Dihetero-substituted metalloprotease inhibitors
08/07/2002CN1088706C Novel heterocyclic amide compounds and medicinal uses thereof
08/07/2002CN1088705C Thienylsulfonyamino (THIO) carbonyl compounds
08/06/2002US6429205 Anticoagulants
08/06/2002CA2223237C 1-phenyl-pyrazole derivatives and their use as parasiticidal agents
08/01/2002WO2002059116A2 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
08/01/2002WO2002059115A1 Oxazolidinones having a benzannulated 6-or 7-membered heterocycle as antibacterial agents
08/01/2002WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002WO2002059110A1 Pyrimidineamines as angiogenesis modulators
08/01/2002WO2002059074A1 Benzylamine analogue
08/01/2002WO2002058698A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
08/01/2002WO2002026733A3 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES
08/01/2002WO2002022572A3 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
08/01/2002WO2002011766A3 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
08/01/2002WO2001078654A3 Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
08/01/2002US20020103387 Compounds which mimic the chemical and biological properties of discodermolide
08/01/2002US20020103377 4-oxo-5-oxazolidineylmethyl derivatives; antibacterials which are active against numerous multidrug-resistant gram positive organisms
08/01/2002US20020103247 Indole and dihydroindole derivatives
08/01/2002US20020103242 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
08/01/2002US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
08/01/2002US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same
08/01/2002US20020103229 Indazole derivatives as JNK inhibitors and compositions and methods related thereto
08/01/2002US20020103227 Nitric oxide synthase inhibitors such as 6(4'-(4-phenethyl-piperazin-1-ylmethyl)-biphenyl-4-yl)-pyridin-2-ylamine for treatment and prevention of central nervous system disorders
08/01/2002US20020103226 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
08/01/2002US20020103202 Heteroaryl-phenyl substituted factor Xa inhibitors
08/01/2002US20020103201 Selective NPY (Y5) antagonists (triazines)
08/01/2002US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone
08/01/2002US20020103186 Use against multiply resistant gram positive pathogens; have a diazine moiety attached to the phenyloxazolidinone which is further substituted by heterocyclic, aryl, substituted aryl, heteroaroamatic ring
08/01/2002US20020103185 Pyrazole derivatives
08/01/2002US20020102608 Library of indolinone compounds for use in the treatment of cancer
08/01/2002US20020102435 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye
08/01/2002CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002CA2435883A1 Benzylamine analogue
08/01/2002CA2424402A1 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
08/01/2002CA2421583A1 Oxazolidinones having a benzannulated 6-or 7-membered heterocycle as antibacterial agents
07/2002
07/31/2002EP1227095A2 A process for the purification of (S)-4-((3-(dimethylamino)ethyl)-1H-indol-5yl)-methyl)-2-oxazolidinone
07/31/2002EP1227093A2 Beta-lactams useful for preparation of taxanes having furyl or thienyl substituted side-chain
07/31/2002EP1227092A2 Isonitrile intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties
07/31/2002EP1227091A2 Formamide intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties
07/31/2002EP1226146A2 Quinoline and naphthyridine carboxylic acid antibacterials
07/31/2002EP1226141A1 Heterocyclic substituted pyrazolones
07/31/2002EP1226136A2 Tyrosine kinase inhibitors
07/31/2002EP1226126A1 Pyrimidine derivatives
07/31/2002EP1226116A1 Processes for the preparation of sumatriptan and related compounds
07/31/2002EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
07/31/2002EP1084121B1 Oxadiazoline derivatives and their use as insecticides
07/31/2002EP0883611B1 Azolyl piperazinyl phenyl oxazolidinone antimicrobials
07/31/2002EP0755930B1 Benzoxazepine derivatives, salts thereof, and drugs containing the same
07/31/2002CN1361775A Novel diphenyl-piperidine derivate
07/31/2002CN1361773A Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
07/31/2002CN1361770A Heteroaromatic ring compounds
07/31/2002CN1361769A Substituted 2-aryl-1,2,4-triazine-3,5-di(thi) one
07/31/2002CN1088459C 1,4-disubstituted piperazines
07/31/2002CN1088359C Medicine for curing cerebrovascular disturbance with psychonosema
07/31/2002CA2369462A1 Nicotinamide acids, amides, and their mimetics active as inhibitors of pde4 isozymes
07/30/2002US6426352 Inhibit the farnesylation of the oncogene protein ras; (+)-4-(3-bromo-8,10-dichloro-6,11-dihydro-5h-benzo(5,6)-cyclohepta(1,2 -b)pyridin-11-yl)-1-(methylsulfonyl)piperidine, for example
07/30/2002US6426318 3-aryl-1,2,4-triazone derivatives with herbicidal properties
07/30/2002CA2344707C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives
07/25/2002WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors
07/25/2002WO2002057240A1 Substituted triazole diamine derivatives as kinase inhibitors
07/25/2002WO2002057236A1 Phenyl derivatives
07/25/2002WO2002057223A2 Compounds azepane, preparation method therefor and pharmaceutical compositions containing said compounds
07/25/2002WO2002056882A1 Quinolines and nitrogenated derivaive thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
07/25/2002WO2002032422A3 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/25/2002WO2002008177A3 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
07/25/2002WO2001066531A8 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase
07/25/2002WO2001036048A9 Phorboxazole derivatives for treating cancer
07/25/2002US20020099208 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
07/25/2002US20020099202 Compoound for use in the sequencing of nucleic acids
07/25/2002US20020099074 Novel anilide compounds and drugs containing the same
07/25/2002US20020099047 Oxazepine derivatives and medicine containing the same
07/25/2002US20020099007 And the prenylation of the oncogene protein Ras; peptidomimetic macrocyclic compounds
07/25/2002DE10102322A1 New disubstituted and trisubstituted benzene derivatives useful as coagulation inhibitors for the treatment of thromboembolic diseases
07/25/2002CA2432870A1 Substituted triazole diamine derivatives as kinase inhibitors
07/24/2002EP1224197A1 Hygromycin derivatives
07/24/2002EP1224186A2 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
07/24/2002EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method
07/24/2002EP1224180A2 Substituted azoles
07/24/2002EP1224177A1 Process for preparing oxazolines from tetrahydrofurans